Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,130 | 815 | 98.8% |
| Education | $166.06 | 3 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,319 | 173 | $0 (2024) |
| Lilly USA, LLC | $1,657 | 114 | $0 (2024) |
| Abbott Laboratories | $1,241 | 61 | $0 (2024) |
| Corcept Therapeutics | $754.76 | 37 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $676.64 | 38 | $0 (2024) |
| Insulet Corporation | $559.20 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $545.09 | 27 | $0 (2024) |
| ABBVIE INC. | $505.42 | 34 | $0 (2024) |
| Esperion Therapeutics, Inc. | $417.69 | 29 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $398.23 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,472 | 184 | Lilly USA, LLC ($602.38) |
| 2023 | $3,118 | 170 | Abbott Laboratories ($465.91) |
| 2022 | $3,215 | 200 | Novo Nordisk Inc ($566.57) |
| 2021 | $3,043 | 194 | Novo Nordisk Inc ($706.19) |
| 2020 | $1,073 | 59 | Novo Nordisk Inc ($300.73) |
| 2019 | $77.35 | 2 | Horizon Therapeutics plc ($40.33) |
| 2018 | $247.12 | 6 | Medtronic MiniMed, Inc. ($142.02) |
| 2017 | $51.85 | 3 | Otsuka America Pharmaceutical, Inc. ($51.85) |
All Payment Transactions
818 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Diabetes Care | ||||||
| 12/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/17/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Diabetes Care | ||||||
| 12/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Endocrinology | ||||||
| 12/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Endocrinology | ||||||
| 11/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Diabetes Care | ||||||
| 11/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $123.88 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Obesity | ||||||
| 11/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Diabetes Care | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/05/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/31/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Endocrinology | ||||||
| 10/30/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $17.58 | General |
| 10/29/2024 | Lilly USA, LLC | JARDIANCE (Drug), LYUMJEV | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 404 | 699 | $185,967 | $58,300 |
| 2022 | 7 | 388 | 651 | $179,719 | $55,943 |
| 2021 | 8 | 283 | 374 | $114,729 | $37,369 |
| 2020 | 3 | 66 | 74 | $22,091 | $7,174 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 423 | $109,219 | $36,921 | 33.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 58 | 58 | $28,794 | $9,168 | 31.8% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 63 | 83 | $24,240 | $6,304 | 26.0% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 26 | 27 | $9,450 | $2,577 | 27.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 29 | 67 | $7,809 | $1,670 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $2,270 | $862.13 | 38.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 17 | 17 | $3,932 | $607.58 | 15.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 11 | $253.00 | $192.00 | 75.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 185 | 396 | $102,247 | $34,343 | 33.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 75 | 75 | $37,234 | $11,601 | 31.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 50 | 57 | $16,647 | $4,389 | 26.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 28 | 72 | $8,392 | $1,849 | 22.0% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 17 | 18 | $6,300 | $1,515 | 24.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $3,811 | $1,456 | 38.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 22 | 22 | $5,089 | $790.38 | 15.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 101 | 186 | $48,025 | $17,455 | 36.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 52 | 52 | $25,815 | $8,110 | 31.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 27 | $9,354 | $3,806 | 40.7% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 34 | 35 | $10,222 | $3,014 | 29.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $8,350 | $1,910 | 22.9% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2021 | 14 | 15 | $5,250 | $1,275 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 19 | $3,318 | $1,108 | 33.4% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 19 | 19 | $4,395 | $691.03 | 15.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 31 | 31 | $12,326 | $3,956 | 32.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 27 | $6,971 | $2,286 | 32.8% |
About Dr. Sadia Ejaz, M.D
Dr. Sadia Ejaz, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Chapel Hill, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2015. The National Provider Identifier (NPI) number assigned to this provider is 1922481977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sadia Ejaz, M.D has received a total of $14,296 in payments from pharmaceutical and medical device companies, with $3,472 received in 2024. These payments were reported across 818 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($14,130).
As a Medicare-enrolled provider, Ejaz has provided services to 1,141 Medicare beneficiaries, totaling 1,798 services with total Medicare billing of $158,785. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Chapel Hill, NC
- Active Since 07/08/2015
- Last Updated 06/26/2018
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1922481977
Products in Payments
- FREESTYLE LIBRE 3 (Device) $1,022
- JARDIANCE (Drug) $947.67
- Ozempic (Drug) $834.43
- Korlym (Drug) $754.76
- MOUNJARO (Drug) $694.09
- Omnipod (Device) $559.20
- Wegovy (Drug) $489.30
- NEXLETOL (Drug) $417.69
- Rybelsus (Drug) $386.21
- XYOSTED (Drug) $337.55
- Saxenda (Drug) $304.58
- AFREZZA (Drug) $299.64
- Vascepa (Drug) $291.82
- CeQur Simplicity (Device) $286.72
- RYBELSUS (Drug) $254.33
- SYNTHROID (Drug) $252.41
- TRULICITY (Drug) $245.48
- FARXIGA (Drug) $234.90
- TEPEZZA (Drug) $233.59
- Kerendia (Drug) $221.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Chapel Hill
Dr. John Buse, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $569,574
Dr. Atil Kargi, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $74,990
Dr. Rebecca Vitale, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $5,000
Dr. Janet Rubin, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $3,818
Karla Pou, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $478.70
Tahereh Ghorbani Rodriguez, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $432.76